Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.
Journal: RMD open
Published: February 16, 2026
Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.
Journal: Rheumatology and therapy
Published: December 11, 2023
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 17, 2023
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies.
Journal: RMD open
Published: November 12, 2021
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.
Journal: Rheumatology and therapy
Published: September 17, 2021
Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
Journal: Rheumatology international
Published: September 10, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
Journal: Clinical rheumatology
Published: February 07, 2018
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys.
Journal: Health and quality of life outcomes
Published: October 05, 2017
Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.
Journal: Rheumatology and therapy
Published: June 22, 2017
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.
Journal: Clinical pharmacology and therapeutics
Published: July 13, 2016
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Journal: Lancet (London, England)
Published: March 22, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026